In March 2025, the company announced new plans for just a immediate-to-consumer supplying of its Wegovy weight loss drug. The company recognized a completely new pharmacy, named NovoCare, which might cost customers $499 per month for entry to the drug, below 50 % the cost of the drug by means of other pharmaceutical distribution networks.[fifty thr